# PK of Levofloxacin in MDR-TB Patients

> **NCT03000517** · — · COMPLETED · sponsor: **University Medical Center Groningen** · enrollment: 20 (actual)

## Conditions studied

- Multi-drug Resistant Tuberculosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03000517
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-04
- **Primary completion:** 2017-10-27
- **Final completion:** 2018-01-24
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03000517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03000517, "PK of Levofloxacin in MDR-TB Patients". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03000517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*